SCHEMBL27363453

SCHEMBL27363453

[CH2]C(C)C[SH](=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14775352 0.72
SCHEMBL27648099 0.69
SCHEMBL27642555 0.67
SCHEMBL27481322 0.67
SCHEMBL27436873 0.67
SCHEMBL27354680 0.67
SCHEMBL14775482 0.67
SCHEMBL27502085 0.67
SCHEMBL19285567 0.67
SCHEMBL27876346 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104193731-A Novel carbamide substituted biphenyl compound, composition and application thereof GUANGDONG HEC PHARMACEUTICAL 2014-12-10 CN claimed
CN-101163678-A Pyridylmethylsulfone derivative DAIICHI SANKYO CO LTD (JP) 2008-04-16 CN claimed
CN-1221534-C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors MERCK FROSST CANADA INC (CA) 2005-10-05 CN claimed
CN-1230187-A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors GLAXO GROUP LTD (GB) 1999-09-29 CN claimed
CN-116196411-A PAPD5 and PAPD7 inhibitors for the treatment of hepatitis B infection 豪夫迈·罗氏有限公司 2023-06-02 CN disclosed
CN-110114358-A Novel compound and pharmacologically acceptable salt thereof 明治制果药业株式会社 2019-08-09 CN disclosed
CN-108601774-A Combination for the treatment of RSV 爱尔兰詹森科学公司 2018-09-28 CN disclosed
CN-108602908-A Support type composite catalyst and the method for preparing olefin polymer using it LG化学株式会社 2018-09-28 CN disclosed
CN-105899508-B Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection 豪夫迈·罗氏有限公司 2017-07-04 CN disclosed
CN-106660991-A Antiproliferative compounds and methods of use thereof 细胞基因公司 2017-05-10 CN disclosed
CN-104540817-B 1,3 dihydro 2H benzimidazole 2 ketone derivatives as the use heterocyclic substituted of respiratory syncytial virus antiviral agent 爱尔兰詹森科学公司 2017-03-01 CN disclosed
CN-105899508-A Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection 豪夫迈·罗氏有限公司 2016-08-24 CN disclosed
CN-1922160-A Compound (I) ASTRAZENECA AB (SE) 2007-02-28 CN disclosed
CN-1922159-A Benzamide derivatives and their use as glucokinase activating agents ASTRAZENECA AB (SE) 2007-02-28 CN disclosed
CN-1806016-A Use of quinaldine and naphthaline derivatives as crystallisation modifiers BASF AG (DE) 2006-07-19 CN disclosed
CN-1774435-A 5-membered heterocyclic derivative DAIICHI SEIYAKU CO (JP) 2006-05-17 CN disclosed
CN-1070480-C 2-amino-benzoxanones for the treatment of viral infections SEARLE & CO (US) 2001-09-05 CN disclosed
CN-1230187-A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors GLAXO GROUP LTD (GB) 1999-09-29 CN disclosed
CN-1151396-A Hydroxylamine derivatives and fungicides containing the same NIHON NOHYAKU CO LTD (JP) 1997-06-11 CN disclosed
CN-86107220-A Δ 2-1, the preparation method and the application method thereof of 2,4 triazolines-5-ketone derivatives 1987-09-30 CN disclosed